Millennium Management’s Dogwood Therapeutics DWTX Stock Holding History

Millennium Management’s Portfolio DWTX Stock Details DWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,151	Closed	-$152K	–	7476
2021 Q3	$152K	Buy	+1,151	New	+$159K	﹤0.01%	6247
2021 Q2	–	Sell	-914	Closed	-$131K	–	7219
2021 Q1	$131K	Buy	914 +86	+10%	+$15K	﹤0.01%	5631
2020 Q4	$155K	Buy	+828	New	+$200K	﹤0.01%	4934

Other funds holding DWTX

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Millennium Management's DWTX Position: Q4 2021 in Review

Millennium Management sold out of Dogwood Therapeutics (DWTX) in Q4 2021, closing a stake of 1,151 shares — an estimated $152K sold.

Millennium Management first reported a position in DWTX in Q4 2020 and held it in 3 quarters. The position peaked at $155K in Q4 2020. 15 funds tracked by Wall St. Rank hold DWTX as of Q4 2021.

Millennium Management reported no remaining Dogwood Therapeutics position as of Q4 2021 after selling out during the quarter.
Millennium Management sold 1,151 Dogwood Therapeutics shares in Q4 2021, an estimated $152K.
Millennium Management first reported a position in Dogwood Therapeutics in Q4 2020 and held it in 3 quarters.
Millennium Management's Dogwood Therapeutics position peaked at $155K in Q4 2020.
15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2021.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.